Form 4: HealthStream Director Deborah Taylor Tate Receives Equity Grant

HealthStream, Inc. Director Deborah Taylor Tate was granted 3,048 Restricted Share Units (RSUs) on May 29, 2025, as part of her compensation, aligning her interests with shareholders.

Summary

• Deborah Taylor Tate, a Director of HealthStream Inc. (HSTM), acquired 3,048 Restricted Share Units (RSUs) on May 29, 2025.
• Each RSU represents the contingent right to receive one share of common stock upon vesting.
• The RSUs are subject to a three-year vesting schedule, contingent upon continued service at the time of vesting.
• Vesting will occur annually in three equal installments, beginning May 29, 2026.
• Following this transaction, Ms. Tate directly beneficially owns 22,575 shares of Common Stock and 3,048 Restricted Share Units.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally positive as it aligns their interests with shareholders and is a standard compensation practice, indicating stability in governance.

Positives

• The grant of Restricted Share Units to a director aligns their long-term interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
• The three-year vesting schedule encourages continued service and commitment from the director.

Future Outlook

The 3,048 Restricted Share Units granted to Director Deborah Taylor Tate are scheduled to vest annually in three equal installments, beginning May 29, 2026, contingent upon her continued service. This indicates future share issuance upon vesting.

Industry Context

The granting of Restricted Share Units (RSUs) to directors is a common practice across various industries, including healthcare technology, as a form of long-term incentive compensation. This aligns the interests of the board members with the long-term performance of the company and its shareholders.

Comparison to Industry Standards

• The structure of this equity grant, involving Restricted Share Units with a multi-year vesting schedule, is a standard and widely accepted practice for compensating non-employee directors in publicly traded companies.
• Companies like Cerner Corporation (now Oracle Health) or Allscripts (now Veradigm) often utilize similar equity-based compensation plans to attract and retain qualified board members, ensuring their commitment to long-term value creation.
• The specific number of units granted would typically be benchmarked against peer companies of similar size and market capitalization within the healthcare IT sector.

Corporate Governance

Related Party Transactions

• The grant of Restricted Share Units to Deborah Taylor Tate, a Director of HealthStream Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.

Next Steps

• Annual vesting of the 3,048 Restricted Share Units in three equal installments, beginning May 29, 2026, contingent on continued service.

Key Dates

Keywords

HealthStream, HSTM, SEC Form 4, Restricted Share Units, RSU, Director Compensation, Equity Grant, Insider Transaction, Corporate Governance